Request for Covid-19 Impact Assessment of this Report
The United States Bumetanide Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Bumetanide Injection market, reaching US$ million by the year 2028. As for the Europe Bumetanide Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Bumetanide Injection players cover Shanxi PUDE Pharmaceutical, Henan Xintai Pharmaceutical, Guilin Pharmaceutical, and Liaoning Yuhuang Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Bumetanide Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by specification: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
2.5mg/10ml
1mg/4ml
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacy
Retail Pharmacy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Shanxi PUDE Pharmaceutical
Henan Xintai Pharmaceutical
Guilin Pharmaceutical
Liaoning Yuhuang Pharmaceutical
Fuzhou FU Yao Pharmaceutical
Ningbo Dahongying Pharmaceutical
Beijing Yongkang Pharmaceutical
Shanghai Harvest Pharmaceutical
Wuhan Jiu'an Pharmaceutical
Hainan Zhuotai Pharmaceutical
Pingguang Pharmaceutical
Hikma Pharmaceuticals
Baxter
Athenex
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bumetanide Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Bumetanide Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Bumetanide Injection by Country/Region, 2017, 2022 & 2028
2.2 Bumetanide Injection Segment by Specification
2.2.1 2.5mg/10ml
2.2.2 1mg/4ml
2.3 Bumetanide Injection Sales by Specification
2.3.1 Global Bumetanide Injection Sales Market Share by Specification (2017-2022)
2.3.2 Global Bumetanide Injection Revenue and Market Share by Specification (2017-2022)
2.3.3 Global Bumetanide Injection Sale Price by Specification (2017-2022)
2.4 Bumetanide Injection Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 Bumetanide Injection Sales by Application
2.5.1 Global Bumetanide Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Bumetanide Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Bumetanide Injection Sale Price by Application (2017-2022)
3 Global Bumetanide Injection by Company
3.1 Global Bumetanide Injection Breakdown Data by Company
3.1.1 Global Bumetanide Injection Annual Sales by Company (2020-2022)
3.1.2 Global Bumetanide Injection Sales Market Share by Company (2020-2022)
3.2 Global Bumetanide Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Bumetanide Injection Revenue by Company (2020-2022)
3.2.2 Global Bumetanide Injection Revenue Market Share by Company (2020-2022)
3.3 Global Bumetanide Injection Sale Price by Company
3.4 Key Manufacturers Bumetanide Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bumetanide Injection Product Location Distribution
3.4.2 Players Bumetanide Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bumetanide Injection by Geographic Region
4.1 World Historic Bumetanide Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Bumetanide Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Bumetanide Injection Annual Revenue by Geographic Region
4.2 World Historic Bumetanide Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Bumetanide Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Bumetanide Injection Annual Revenue by Country/Region
4.3 Americas Bumetanide Injection Sales Growth
4.4 APAC Bumetanide Injection Sales Growth
4.5 Europe Bumetanide Injection Sales Growth
4.6 Middle East & Africa Bumetanide Injection Sales Growth
5 Americas
5.1 Americas Bumetanide Injection Sales by Country
5.1.1 Americas Bumetanide Injection Sales by Country (2017-2022)
5.1.2 Americas Bumetanide Injection Revenue by Country (2017-2022)
5.2 Americas Bumetanide Injection Sales by Specification
5.3 Americas Bumetanide Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bumetanide Injection Sales by Region
6.1.1 APAC Bumetanide Injection Sales by Region (2017-2022)
6.1.2 APAC Bumetanide Injection Revenue by Region (2017-2022)
6.2 APAC Bumetanide Injection Sales by Specification
6.3 APAC Bumetanide Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bumetanide Injection by Country
7.1.1 Europe Bumetanide Injection Sales by Country (2017-2022)
7.1.2 Europe Bumetanide Injection Revenue by Country (2017-2022)
7.2 Europe Bumetanide Injection Sales by Specification
7.3 Europe Bumetanide Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bumetanide Injection by Country
8.1.1 Middle East & Africa Bumetanide Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Bumetanide Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Bumetanide Injection Sales by Specification
8.3 Middle East & Africa Bumetanide Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bumetanide Injection
10.3 Manufacturing Process Analysis of Bumetanide Injection
10.4 Industry Chain Structure of Bumetanide Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bumetanide Injection Distributors
11.3 Bumetanide Injection Customer
12 World Forecast Review for Bumetanide Injection by Geographic Region
12.1 Global Bumetanide Injection Market Size Forecast by Region
12.1.1 Global Bumetanide Injection Forecast by Region (2023-2028)
12.1.2 Global Bumetanide Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bumetanide Injection Forecast by Specification
12.7 Global Bumetanide Injection Forecast by Application
13 Key Players Analysis
13.1 Shanxi PUDE Pharmaceutical
13.1.1 Shanxi PUDE Pharmaceutical Company Information
13.1.2 Shanxi PUDE Pharmaceutical Bumetanide Injection Product Offered
13.1.3 Shanxi PUDE Pharmaceutical Bumetanide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Shanxi PUDE Pharmaceutical Main Business Overview
13.1.5 Shanxi PUDE Pharmaceutical Latest Developments
13.2 Henan Xintai Pharmaceutical
13.2.1 Henan Xintai Pharmaceutical Company Information
13.2.2 Henan Xintai Pharmaceutical Bumetanide Injection Product Offered
13.2.3 Henan Xintai Pharmaceutical Bumetanide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Henan Xintai Pharmaceutical Main Business Overview
13.2.5 Henan Xintai Pharmaceutical Latest Developments
13.3 Guilin Pharmaceutical
13.3.1 Guilin Pharmaceutical Company Information
13.3.2 Guilin Pharmaceutical Bumetanide Injection Product Offered
13.3.3 Guilin Pharmaceutical Bumetanide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Guilin Pharmaceutical Main Business Overview
13.3.5 Guilin Pharmaceutical Latest Developments
13.4 Liaoning Yuhuang Pharmaceutical
13.4.1 Liaoning Yuhuang Pharmaceutical Company Information
13.4.2 Liaoning Yuhuang Pharmaceutical Bumetanide Injection Product Offered
13.4.3 Liaoning Yuhuang Pharmaceutical Bumetanide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Liaoning Yuhuang Pharmaceutical Main Business Overview
13.4.5 Liaoning Yuhuang Pharmaceutical Latest Developments
13.5 Fuzhou FU Yao Pharmaceutical
13.5.1 Fuzhou FU Yao Pharmaceutical Company Information
13.5.2 Fuzhou FU Yao Pharmaceutical Bumetanide Injection Product Offered
13.5.3 Fuzhou FU Yao Pharmaceutical Bumetanide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Fuzhou FU Yao Pharmaceutical Main Business Overview
13.5.5 Fuzhou FU Yao Pharmaceutical Latest Developments
13.6 Ningbo Dahongying Pharmaceutical
13.6.1 Ningbo Dahongying Pharmaceutical Company Information
13.6.2 Ningbo Dahongying Pharmaceutical Bumetanide Injection Product Offered
13.6.3 Ningbo Dahongying Pharmaceutical Bumetanide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Ningbo Dahongying Pharmaceutical Main Business Overview
13.6.5 Ningbo Dahongying Pharmaceutical Latest Developments
13.7 Beijing Yongkang Pharmaceutical
13.7.1 Beijing Yongkang Pharmaceutical Company Information
13.7.2 Beijing Yongkang Pharmaceutical Bumetanide Injection Product Offered
13.7.3 Beijing Yongkang Pharmaceutical Bumetanide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Beijing Yongkang Pharmaceutical Main Business Overview
13.7.5 Beijing Yongkang Pharmaceutical Latest Developments
13.8 Shanghai Harvest Pharmaceutical
13.8.1 Shanghai Harvest Pharmaceutical Company Information
13.8.2 Shanghai Harvest Pharmaceutical Bumetanide Injection Product Offered
13.8.3 Shanghai Harvest Pharmaceutical Bumetanide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Shanghai Harvest Pharmaceutical Main Business Overview
13.8.5 Shanghai Harvest Pharmaceutical Latest Developments
13.9 Wuhan Jiu'an Pharmaceutical
13.9.1 Wuhan Jiu'an Pharmaceutical Company Information
13.9.2 Wuhan Jiu'an Pharmaceutical Bumetanide Injection Product Offered
13.9.3 Wuhan Jiu'an Pharmaceutical Bumetanide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Wuhan Jiu'an Pharmaceutical Main Business Overview
13.9.5 Wuhan Jiu'an Pharmaceutical Latest Developments
13.10 Hainan Zhuotai Pharmaceutical
13.10.1 Hainan Zhuotai Pharmaceutical Company Information
13.10.2 Hainan Zhuotai Pharmaceutical Bumetanide Injection Product Offered
13.10.3 Hainan Zhuotai Pharmaceutical Bumetanide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Hainan Zhuotai Pharmaceutical Main Business Overview
13.10.5 Hainan Zhuotai Pharmaceutical Latest Developments
13.11 Pingguang Pharmaceutical
13.11.1 Pingguang Pharmaceutical Company Information
13.11.2 Pingguang Pharmaceutical Bumetanide Injection Product Offered
13.11.3 Pingguang Pharmaceutical Bumetanide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Pingguang Pharmaceutical Main Business Overview
13.11.5 Pingguang Pharmaceutical Latest Developments
13.12 Hikma Pharmaceuticals
13.12.1 Hikma Pharmaceuticals Company Information
13.12.2 Hikma Pharmaceuticals Bumetanide Injection Product Offered
13.12.3 Hikma Pharmaceuticals Bumetanide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Hikma Pharmaceuticals Main Business Overview
13.12.5 Hikma Pharmaceuticals Latest Developments
13.13 Baxter
13.13.1 Baxter Company Information
13.13.2 Baxter Bumetanide Injection Product Offered
13.13.3 Baxter Bumetanide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Baxter Main Business Overview
13.13.5 Baxter Latest Developments
13.14 Athenex
13.14.1 Athenex Company Information
13.14.2 Athenex Bumetanide Injection Product Offered
13.14.3 Athenex Bumetanide Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Athenex Main Business Overview
13.14.5 Athenex Latest Developments
14 Research Findings and Conclusion
Table 1. Bumetanide Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Bumetanide Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 2.5mg/10ml
Table 4. Major Players of 1mg/4ml
Table 5. Global Bumetanide Injection Sales by Specification (2017-2022) & (K Units)
Table 6. Global Bumetanide Injection Sales Market Share by Specification (2017-2022)
Table 7. Global Bumetanide Injection Revenue by Specification (2017-2022) & ($ million)
Table 8. Global Bumetanide Injection Revenue Market Share by Specification (2017-2022)
Table 9. Global Bumetanide Injection Sale Price by Specification (2017-2022) & (US$/Unit)
Table 10. Global Bumetanide Injection Sales by Application (2017-2022) & (K Units)
Table 11. Global Bumetanide Injection Sales Market Share by Application (2017-2022)
Table 12. Global Bumetanide Injection Revenue by Application (2017-2022)
Table 13. Global Bumetanide Injection Revenue Market Share by Application (2017-2022)
Table 14. Global Bumetanide Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Bumetanide Injection Sales by Company (2020-2022) & (K Units)
Table 16. Global Bumetanide Injection Sales Market Share by Company (2020-2022)
Table 17. Global Bumetanide Injection Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Bumetanide Injection Revenue Market Share by Company (2020-2022)
Table 19. Global Bumetanide Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Bumetanide Injection Producing Area Distribution and Sales Area
Table 21. Players Bumetanide Injection Products Offered
Table 22. Bumetanide Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bumetanide Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Bumetanide Injection Sales Market Share Geographic Region (2017-2022)
Table 27. Global Bumetanide Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Bumetanide Injection Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Bumetanide Injection Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Bumetanide Injection Sales Market Share by Country/Region (2017-2022)
Table 31. Global Bumetanide Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Bumetanide Injection Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Bumetanide Injection Sales by Country (2017-2022) & (K Units)
Table 34. Americas Bumetanide Injection Sales Market Share by Country (2017-2022)
Table 35. Americas Bumetanide Injection Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Bumetanide Injection Revenue Market Share by Country (2017-2022)
Table 37. Americas Bumetanide Injection Sales by Type (2017-2022) & (K Units)
Table 38. Americas Bumetanide Injection Sales Market Share by Specification (2017-2022)
Table 39. Americas Bumetanide Injection Sales by Application (2017-2022) & (K Units)
Table 40. Americas Bumetanide Injection Sales Market Share by Application (2017-2022)
Table 41. APAC Bumetanide Injection Sales by Region (2017-2022) & (K Units)
Table 42. APAC Bumetanide Injection Sales Market Share by Region (2017-2022)
Table 43. APAC Bumetanide Injection Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Bumetanide Injection Revenue Market Share by Region (2017-2022)
Table 45. APAC Bumetanide Injection Sales by Specification (2017-2022) & (K Units)
Table 46. APAC Bumetanide Injection Sales Market Share by Specification (2017-2022)
Table 47. APAC Bumetanide Injection Sales by Application (2017-2022) & (K Units)
Table 48. APAC Bumetanide Injection Sales Market Share by Application (2017-2022)
Table 49. Europe Bumetanide Injection Sales by Country (2017-2022) & (K Units)
Table 50. Europe Bumetanide Injection Sales Market Share by Country (2017-2022)
Table 51. Europe Bumetanide Injection Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Bumetanide Injection Revenue Market Share by Country (2017-2022)
Table 53. Europe Bumetanide Injection Sales by Type (2017-2022) & (K Units)
Table 54. Europe Bumetanide Injection Sales Market Share by Specification (2017-2022)
Table 55. Europe Bumetanide Injection Sales by Application (2017-2022) & (K Units)
Table 56. Europe Bumetanide Injection Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Bumetanide Injection Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Bumetanide Injection Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Bumetanide Injection Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Bumetanide Injection Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Bumetanide Injection Sales by Specification (2017-2022) & (K Units)
Table 62. Middle East & Africa Bumetanide Injection Sales Market Share by Specification (2017-2022)
Table 63. Middle East & Africa Bumetanide Injection Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Bumetanide Injection Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Bumetanide Injection
Table 66. Key Market Challenges & Risks of Bumetanide Injection
Table 67. Key Industry Trends of Bumetanide Injection
Table 68. Bumetanide Injection Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Bumetanide Injection Distributors List
Table 71. Bumetanide Injection Customer List
Table 72. Global Bumetanide Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Bumetanide Injection Sales Market Forecast by Region
Table 74. Global Bumetanide Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Bumetanide Injection Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Bumetanide Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Bumetanide Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Bumetanide Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Bumetanide Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Bumetanide Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Bumetanide Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Bumetanide Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Bumetanide Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Bumetanide Injection Sales Forecast by Specification (2023-2028) & (K Units)
Table 85. Global Bumetanide Injection Sales Market Share Forecast by Specification (2023-2028)
Table 86. Global Bumetanide Injection Revenue Forecast by Specification (2023-2028) & ($ Millions)
Table 87. Global Bumetanide Injection Revenue Market Share Forecast by Specification (2023-2028)
Table 88. Global Bumetanide Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Bumetanide Injection Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Bumetanide Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Bumetanide Injection Revenue Market Share Forecast by Application (2023-2028)
Table 92. Shanxi PUDE Pharmaceutical Basic Information, Bumetanide Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Shanxi PUDE Pharmaceutical Bumetanide Injection Product Offered
Table 94. Shanxi PUDE Pharmaceutical Bumetanide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Shanxi PUDE Pharmaceutical Main Business
Table 96. Shanxi PUDE Pharmaceutical Latest Developments
Table 97. Henan Xintai Pharmaceutical Basic Information, Bumetanide Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Henan Xintai Pharmaceutical Bumetanide Injection Product Offered
Table 99. Henan Xintai Pharmaceutical Bumetanide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Henan Xintai Pharmaceutical Main Business
Table 101. Henan Xintai Pharmaceutical Latest Developments
Table 102. Guilin Pharmaceutical Basic Information, Bumetanide Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Guilin Pharmaceutical Bumetanide Injection Product Offered
Table 104. Guilin Pharmaceutical Bumetanide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Guilin Pharmaceutical Main Business
Table 106. Guilin Pharmaceutical Latest Developments
Table 107. Liaoning Yuhuang Pharmaceutical Basic Information, Bumetanide Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Liaoning Yuhuang Pharmaceutical Bumetanide Injection Product Offered
Table 109. Liaoning Yuhuang Pharmaceutical Bumetanide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Liaoning Yuhuang Pharmaceutical Main Business
Table 111. Liaoning Yuhuang Pharmaceutical Latest Developments
Table 112. Fuzhou FU Yao Pharmaceutical Basic Information, Bumetanide Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Fuzhou FU Yao Pharmaceutical Bumetanide Injection Product Offered
Table 114. Fuzhou FU Yao Pharmaceutical Bumetanide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Fuzhou FU Yao Pharmaceutical Main Business
Table 116. Fuzhou FU Yao Pharmaceutical Latest Developments
Table 117. Ningbo Dahongying Pharmaceutical Basic Information, Bumetanide Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Ningbo Dahongying Pharmaceutical Bumetanide Injection Product Offered
Table 119. Ningbo Dahongying Pharmaceutical Bumetanide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Ningbo Dahongying Pharmaceutical Main Business
Table 121. Ningbo Dahongying Pharmaceutical Latest Developments
Table 122. Beijing Yongkang Pharmaceutical Basic Information, Bumetanide Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Beijing Yongkang Pharmaceutical Bumetanide Injection Product Offered
Table 124. Beijing Yongkang Pharmaceutical Bumetanide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Beijing Yongkang Pharmaceutical Main Business
Table 126. Beijing Yongkang Pharmaceutical Latest Developments
Table 127. Shanghai Harvest Pharmaceutical Basic Information, Bumetanide Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Shanghai Harvest Pharmaceutical Bumetanide Injection Product Offered
Table 129. Shanghai Harvest Pharmaceutical Bumetanide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Shanghai Harvest Pharmaceutical Main Business
Table 131. Shanghai Harvest Pharmaceutical Latest Developments
Table 132. Wuhan Jiu'an Pharmaceutical Basic Information, Bumetanide Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Wuhan Jiu'an Pharmaceutical Bumetanide Injection Product Offered
Table 134. Wuhan Jiu'an Pharmaceutical Bumetanide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Wuhan Jiu'an Pharmaceutical Main Business
Table 136. Wuhan Jiu'an Pharmaceutical Latest Developments
Table 137. Hainan Zhuotai Pharmaceutical Basic Information, Bumetanide Injection Manufacturing Base, Sales Area and Its Competitors
Table 138. Hainan Zhuotai Pharmaceutical Bumetanide Injection Product Offered
Table 139. Hainan Zhuotai Pharmaceutical Bumetanide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Hainan Zhuotai Pharmaceutical Main Business
Table 141. Hainan Zhuotai Pharmaceutical Latest Developments
Table 142. Pingguang Pharmaceutical Basic Information, Bumetanide Injection Manufacturing Base, Sales Area and Its Competitors
Table 143. Pingguang Pharmaceutical Bumetanide Injection Product Offered
Table 144. Pingguang Pharmaceutical Bumetanide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Pingguang Pharmaceutical Main Business
Table 146. Pingguang Pharmaceutical Latest Developments
Table 147. Hikma Pharmaceuticals Basic Information, Bumetanide Injection Manufacturing Base, Sales Area and Its Competitors
Table 148. Hikma Pharmaceuticals Bumetanide Injection Product Offered
Table 149. Hikma Pharmaceuticals Bumetanide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Hikma Pharmaceuticals Main Business
Table 151. Hikma Pharmaceuticals Latest Developments
Table 152. Baxter Basic Information, Bumetanide Injection Manufacturing Base, Sales Area and Its Competitors
Table 153. Baxter Bumetanide Injection Product Offered
Table 154. Baxter Bumetanide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Baxter Main Business
Table 156. Baxter Latest Developments
Table 157. Athenex Basic Information, Bumetanide Injection Manufacturing Base, Sales Area and Its Competitors
Table 158. Athenex Bumetanide Injection Product Offered
Table 159. Athenex Bumetanide Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Athenex Main Business
Table 161. Athenex Latest Developments
List of Figures
Figure 1. Picture of Bumetanide Injection
Figure 2. Bumetanide Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bumetanide Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Bumetanide Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Bumetanide Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 2.5mg/10ml
Figure 10. Product Picture of 1mg/4ml
Figure 11. Global Bumetanide Injection Sales Market Share by Specification in 2021
Figure 12. Global Bumetanide Injection Revenue Market Share by Specification (2017-2022)
Figure 13. Bumetanide Injection Consumed in Hospital Pharmacy
Figure 14. Global Bumetanide Injection Market: Hospital Pharmacy (2017-2022) & (K Units)
Figure 15. Bumetanide Injection Consumed in Retail Pharmacy
Figure 16. Global Bumetanide Injection Market: Retail Pharmacy (2017-2022) & (K Units)
Figure 17. Bumetanide Injection Consumed in Others
Figure 18. Global Bumetanide Injection Market: Others (2017-2022) & (K Units)
Figure 19. Global Bumetanide Injection Sales Market Share by Application (2017-2022)
Figure 20. Global Bumetanide Injection Revenue Market Share by Application in 2021
Figure 21. Bumetanide Injection Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Bumetanide Injection Revenue Market Share by Company in 2021
Figure 23. Global Bumetanide Injection Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Bumetanide Injection Revenue Market Share by Geographic Region in 2021
Figure 25. Global Bumetanide Injection Sales Market Share by Region (2017-2022)
Figure 26. Global Bumetanide Injection Revenue Market Share by Country/Region in 2021
Figure 27. Americas Bumetanide Injection Sales 2017-2022 (K Units)
Figure 28. Americas Bumetanide Injection Revenue 2017-2022 ($ Millions)
Figure 29. APAC Bumetanide Injection Sales 2017-2022 (K Units)
Figure 30. APAC Bumetanide Injection Revenue 2017-2022 ($ Millions)
Figure 31. Europe Bumetanide Injection Sales 2017-2022 (K Units)
Figure 32. Europe Bumetanide Injection Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Bumetanide Injection Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Bumetanide Injection Revenue 2017-2022 ($ Millions)
Figure 35. Americas Bumetanide Injection Sales Market Share by Country in 2021
Figure 36. Americas Bumetanide Injection Revenue Market Share by Country in 2021
Figure 37. United States Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Bumetanide Injection Sales Market Share by Region in 2021
Figure 42. APAC Bumetanide Injection Revenue Market Share by Regions in 2021
Figure 43. China Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Bumetanide Injection Sales Market Share by Country in 2021
Figure 50. Europe Bumetanide Injection Revenue Market Share by Country in 2021
Figure 51. Germany Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Bumetanide Injection Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Bumetanide Injection Revenue Market Share by Country in 2021
Figure 58. Egypt Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Bumetanide Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Bumetanide Injection in 2021
Figure 64. Manufacturing Process Analysis of Bumetanide Injection
Figure 65. Industry Chain Structure of Bumetanide Injection
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...